|
AGFA Utilizes JProxy to Deliver Newest Version of IMPAX® WEB1000™ Software
Plantation, FL, January 20, 2005, JProxy, LLC (http://www.jproxy.com), an innovation leader
in distributed computing technologies, has been selected by Agfa (http://www.agfa.com),
a worldwide leader in digital imaging solutions, to utilize JProxy to bring the functionality
of Agfa's IMPAX WEB1000 5.0 software to healthcare facilities and clinicians anywhere in the world.
IMPAX WEB1000 5.0 software offers on-demand synchronized and secure access to clinical
results anywhere, anytime via a web browser using JProxy's client small enterprise runtime
footprint.
The IMPAX WEB1000 DICOM Web Server with embedded JProxy software, provides PACS administrators,
radiologists and clinicians with on-demand, cost-effective, secure access to images and reports
from virtually any location - including any department, office or home. PACS and other modalities
push images to the IMPAX WEB1000 server, and at the user's option will store the images in either
lossless or lossy format. Authorized users can then access images from the server from any location
using a web browser.
JProxy software seamlessly integrates with the Java 2 Platform, Enterprise Edition (J2EE™)
technology stack used by IMPAX WEB1000, which enables the user to quickly launch a web browser
while preserving security and responsiveness to user requests.
"We are very pleased that JProxy's product has been selected by Agfa. JProxy is about
simplifying enterprise Sun Java development, deployment and delivering rich thin enterprise
clients onto the user's web browsers. Agfa's deployment of JProxy demonstrates that it is
possible to deliver highly complex graphical user Interfaces that remotely access application
servers and yet remain very thin and instantly available at any location," said Eugene Yakushev,
the President and co-founder of JProxy, LLC.
"This is another example of Agfa's ability to integrate 'best of breed' third party solutions into
its product lines to further enhance our customers' experience" said Dave Wilson, Global PACS Marketing Manager,
Agfa HealthCare. "We are glad to have teamed with JProxy to improve upon our IMPAX WEB1000 software's performance.
Agfa strives to build upon its solid foundation as a leading PACS provider and improving relationships
such as the one with JProxy."
About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging companies. Agfa develops, manufactures
and markets analogue and digital systems, intended mainly for the graphics industry and healthcare.
Agfa's headquarters are in Mortsel, Belgium. The company is active in 40 countries and has 120
agents throughout the world. Together they achieved a turnover of 4,215 million Euros in 2003.
Product and company information can be found on Agfa's home page on the World Wide Web at: www.agfa.com.
About JProxy, LLC
JProxy, LLC is a software research and development company that concentrates on innovative implementations
that enhance current distributed computing paradigms. JProxy, LLC provides new distributed tools to
the development community and businesses. Our flagship product, JProxy, is a generic,
declarative Java Remoting System implemented in pure Sun Java technology, which allows remoting
an arbitrary Java interface with no code change. This product enhances remoting capabilities of
the general-purpose Java programming language as well as remoting capabilities of many software
vendors J2EE Application Server implementations. JProxy software consists of a thin client runtime
(about 100 KB) and a generic, declarative remoter server. JProxy software uses HTTP protocol
as a transport to enable Java systems to communicate over the Internet networks and integrates with
most popular Application Servers and Servlet Engines. More information may be found at www.jproxy.com
Agfa, the Agfa-Rhombus, IMPAX and WEB1000 are trademarks or registered trademarks of Agfa Corporation or its affiliates.
JProxy is a trademark of JProxy, LLC. Sun, J2EE and Java are trademarks or registered trademarks of
Sun Microsystems, Inc. in the U.S. or other countries. All rights reserved.
|